Primo Chemicals to Invest ₹21 Crore in 50 MW Solar SPV, Expects ₹24 Crore Annual Savings
Primo Chemicals will invest ₹21 crore for a 26% stake in TPC Private Limited, an SPV for a 50 MW solar power plant. The investment is projected to yield annual cost savings of up to ₹24 crore upon plant commissioning. The SPV was incorporated on February 13, 2026.
The investment of ₹21 crore and potential savings of ₹24 crore annually are material but do not represent a fundamental shift in the company's core business or financial structure, hence a medium impact.
The announcement details a strategic investment that is expected to generate significant cost savings for the company, indicating a positive development.
Primo Chemicals Limited (the Company) has announced an update regarding its investment in a Special Purpose Vehicle (SPV) for a 50 MW solar power plant. The SPV, named TPC Private Limited, was incorporated on February 13, 2026, with Arpa Infrastructure Developers Private Limited holding 51% and Sun Photonics Private Limited holding 49%.
The Company's Board of Directors, in a meeting held on May 5, 2026, approved the term sheet and incorporation structure of the SPV. Primo Chemicals will invest ₹21 crore in one or more tranches to acquire a 26% equity stake in TPC Private Limited. This investment is expected to result in cost savings of up to ₹24 crore per annum upon commissioning of the solar power plant under a captive mode on an OPEX model.
The SPV is being established to own and operate the 50 MW solar power plant in accordance with open access and captive power policies. The Company is currently in the process of executing the Power Purchase Agreement and Share Subscription and Shareholders Agreement, with further updates to be provided upon their execution. The necessary governmental and regulatory approvals under the Electricity Act, 2003, and related rules are being pursued.
What to do with a filing like this
Primo Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Primo Chemicals Limited. Read the original for the full detail.